PRECISION BIOSCIENCES INC
DTIL
25 insider filings · Latest: Sep 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Sep 30 8:15 PM | Stanley FrankelDirector | Purchase | 1,000 | $6.00 | $6.0K | 41,478(D) | View → |
| Sep 25, 2026 | Sep 29 11:00 AM | Melinda BrownDirector | Purchase | 1,135 | $6.27 | $7.1K | 45,481(D) | View → |
| Sep 25, 2026 | Sep 29 11:00 AM | Geno J GermanoDirector | Purchase | 2,609 | $6.28 | $16.4K | 47,492(D) | View → |
| Feb 18, 2026 | Feb 19 9:31 PM | Michael AmorosoDirector, President and CEO | Sale | 20,559 | $3.84 | $78.9K | 243,392(D) | View → |
| Feb 18, 2026 | Feb 19 9:31 PM | John Alexander KellyChief Financial Officer | Sale | 8,149 | $3.84 | $31.3K | 125,883(D) | View → |
| Feb 18, 2026 | Feb 19 9:30 PM | Dario ScimecaGeneral Counsel and Secretary | Sale | 4,925 | $3.84 | $18.9K | 56,457(D) | View → |
| Feb 18, 2026 | Feb 19 9:30 PM | Jefferson J. SmithChief Research Officer | Sale | 4,925 | $3.84 | $18.9K | 121,926(D) | View → |
| Feb 18, 2026 | Feb 18 10:05 PM | SMITH J. JEFFERSON | Proposed Sale | 4,925 | $3.84 | $18.9K | — | View → |
| Feb 18, 2026 | Feb 18 9:31 PM | Scimeca Dario | Proposed Sale | 4,925 | $3.84 | $18.9K | — | View → |
| Feb 18, 2026 | Feb 18 9:30 PM | Amoroso Michael | Proposed Sale | 20,559 | $3.84 | $79.0K | — | View → |
| Feb 18, 2026 | Feb 18 9:19 PM | Kelly John Alexander | Proposed Sale | 8,149 | $3.84 | $31.3K | — | View → |
| Jan 22, 2026 | Jan 22 11:49 PM | Michael AmorosoDirector, President and CEO | Sale | 34,799 | $4.17 | $145.1K | 196,154(D) | View → |
| Jan 21, 2026 | Jan 22 11:48 PM | Dario ScimecaGeneral Counsel and Secretary | Sale | 8,854 | $4.03 | $35.7K | 44,715(D) | View → |
| Jan 21, 2026 | Jan 22 11:48 PM | John Alexander KellyChief Financial Officer | Sale | 15,213 | $4.03 | $61.3K | 106,448(D) | View → |
| Jan 21, 2026 | Jan 22 11:48 PM | Jefferson J. SmithChief Research Officer | Sale | 10,200 | $4.03 | $41.1K | 110,184(D) | View → |
| Jan 22, 2026 | Jan 22 8:19 PM | Amoroso Michael | Proposed Sale | 34,799 | $4.17 | $145.2K | — | View → |
| Jan 21, 2026 | Jan 21 9:19 PM | Scimeca Dario | Proposed Sale | 8,854 | $4.03 | $35.7K | — | View → |
| Jan 21, 2026 | Jan 21 9:14 PM | SMITH J. JEFFERSON | Proposed Sale | 10,200 | $4.03 | $41.1K | — | View → |
| Jan 21, 2026 | Jan 21 9:07 PM | Kelly John Alexander | Proposed Sale | 15,213 | $4.03 | $61.3K | — | View → |
| Nov 3, 2025 | Nov 3 8:16 PM | Kelly John Alexander | Proposed Sale | 1,303 | $6.49 | $8.5K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 11:39 AM | Melinda BrownDirector | Grant/Award | 20,979 | — | 20,979(D) | View → |
| Jun 3, 2026 | Jun 5 11:38 AM | Stanley FrankelDirector | Grant/Award | 20,979 | — | 20,979(D) | View → |
| Jun 3, 2026 | Jun 5 11:37 AM | Geno J GermanoDirector | Grant/Award | 20,979 | — | 20,979(D) | View → |
| Jun 3, 2026 | Jun 5 11:36 AM | Shari Lisa PireDirector | Grant/Award | 20,979 | — | 20,979(D) | View → |
| Jun 3, 2026 | Jun 5 11:35 AM | Kevin BuehlerDirector | Grant/Award | 20,979 | — | 20,979(D) | View → |
| Jun 1, 2026 | Jun 3 8:06 PM | Jefferson J. SmithChief Research Officer | Grant/Award | 57,389 | — | 57,389(D) | View → |
| Jun 1, 2026 | Jun 3 8:06 PM | Dario ScimecaGeneral Counsel and Secretary | Grant/Award | 107,604 | — | 107,604(D) | View → |
| Jun 1, 2026 | Jun 3 8:05 PM | John Alexander KellyChief Financial Officer | Grant/Award | 193,688 | — | 193,688(D) | View → |
| Jun 1, 2026 | Jun 3 8:05 PM | Michael AmorosoDirector, President and CEO | Grant/Award | 573,888 | — | 573,888(D) | View → |
| May 20, 2026 | May 22 11:31 AM | Kevin BuehlerDirector | Option Exercise | 21,000 | — | 0(D) | View → |
| May 20, 2026 | May 22 11:31 AM | Stanley FrankelDirector | Option Exercise | 21,000 | — | 0(D) | View → |
| May 20, 2026 | May 22 11:30 AM | Melinda BrownDirector | Option Exercise | 21,000 | — | 0(D) | View → |
| May 20, 2026 | May 22 11:30 AM | Shari Lisa PireDirector | Option Exercise | 21,000 | — | 0(D) | View → |
| May 20, 2026 | May 22 11:30 AM | Geno J GermanoDirector | Option Exercise | 21,000 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 9:31 PM | Michael AmorosoDirector, President and CEO | Option Exercise | 67,797 | — | 135,593(D) | View → |
| Feb 17, 2026 | Feb 19 9:31 PM | John Alexander KellyChief Financial Officer | Option Exercise | 27,584 | — | 55,166(D) | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Dario ScimecaGeneral Counsel and Secretary | Option Exercise | 16,667 | — | 33,333(D) | View → |
| Feb 17, 2026 | Feb 19 9:30 PM | Jefferson J. SmithChief Research Officer | Option Exercise | 16,667 | — | 33,333(D) | View → |
| Jan 20, 2026 | Jan 22 11:49 PM | Michael AmorosoDirector, President and CEO | Option Exercise | 115,378 | — | 69,421(D) | View → |
| Jan 20, 2026 | Jan 22 11:48 PM | Dario ScimecaGeneral Counsel and Secretary | Option Exercise | 25,311 | — | 14,907(D) | View → |
Page 1 of 2
Next →